Vivanza Biosciences Board to Meet May 4 for Q4/FY26 Results

Vivanza Biosciences Ltd has announced that its Board of Directors will convene on Monday, May 4, 2026. The primary agenda for the meeting is to consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and fiscal year ended March 31, 2026. Additionally, the trading window for dealing in the company's securities remains closed for designated persons until 48 hours after the declaration of these financial results, in compliance with SEBI Insider Trading Regulations.